DMS Imaging

Equities

DMSIM

BE0974289218

Healthcare Facilities & Services

Market Closed - Euronext Bruxelles 11:35:18 2024-04-24 am EDT 5-day change 1st Jan Change
0.0198 EUR -2.94% Intraday chart for DMS Imaging -7.48% -15.74%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023 CI
DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Diagnostic Medical Systems Unit Receives Order for Radiology Tables in Italy MT
DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2022 CI
DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Diagnostic Medical Systems Takes Majority Stake In Asit Biotech MT
Global markets live: Microsoft, Apple, The Boeing Company, AT&T, Activision Blizzard... Our Logo
Asit Biotech S.A. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
GLOBAL MARKETS LIVE: UBS eying new acquisition, Deutsche Bank’s suspicious transactions… Our Logo
Asit Biotech S.A. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
ASIT Biotech S.A. Announces Board Changes CI
ASIT biotech Discloses Next Steps Following gp-ASIT+TM Phase III Results CI
ASIT Biotech gp-ASIT+™ Phase III Trial in Grass Pollen Allergy Did Not Meet the Primary Endpoint CI
ASIT Biotech Announces the Publication of a Mechanistic Study of Gp-ASIT+™, its Lead Product Candidate in Phase III CI
ASIT Biotech Receives GMP Certification for Its Manufacturing Site in Liège, Belgium CI
Biotech Tools Sa Reports Earnings Results for the Half Year Ended June 30, 2019 CI
ASIT biotech Confirms on Track for Phase III Results of gp-ASIT+™ in December 2019 CI
ASIT Biotech Raises EUR 9.225 Million in A Private Placement of Convertible Notes CI
ASIT Biotech S.A. announced that it has received €9.225 million in funding CI
ASIT Biotech S.A. announced a financing transaction CI
ASIT Biotech Announces the Achievement of New Clinical and Corporate Development Milestones CI
ASIT Biotech Appoints Frank Hazevoets as Chief Financial Officer CI
ASIT Biotech S.A. Reports Earnings Results for the Full Year Ended December 31, 2018 CI
ASIT Biotech S.A. Provides Clinical Update CI
ASIT Biotech S.A. Reveals the Mode of Action of its Immunotherapy Product for Allergic Rhinitis, gp-ASIT+™, in the Journal of Allergy and Clinical Immunology CI
Chart DMS Imaging
More charts
DMS Imaging specializes in the design and manufacture of imaging systems for digital and conventional radiology and bone densitometry. DMS Imaging offers radiology equipment (mobile radiology units, floating panel tables, mobile C-arm for operating room, etc.), ultrasound bone densitometers (for the reconstruction of bone microarchitecture), X-ray bone densitometers (for the measurement of bone density), etc. Net sales are distributed geographically as follows: Europe (61.3%), North and South America (18.4%), Asia (7.1%), Middle East (4.5%), Africa (3 .9%), Oceania (1.1%) and other (3.7%).
More about the company
  1. Stock Market
  2. Equities
  3. DMSIM Stock
  4. News DMS Imaging
  5. Diagnostic Medical Systems Takes Majority Stake In Asit Biotech